[Translated article] Differentiating Keratoacanthoma From Squamous Cell Carcinoma: Are We Losing the Battle or Our Bearings? — Comment on “Intralesional Methotrexate for Keratoacanthomas: A Case Series”
Actas Dermo-Sifiliográficas · 2024
DOI: 10.1016/j.ad.2024.01.010 ↗Kurz gefasst
Leserbrief in der Zeitschrift Actas Dermo-Sifiliográficas, 2024. Verfasst von P López Sanz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Dermatología, Hospital General Universitario de Albacete, Albacete, Spain. Electronic address: lopezsanzpablo@gmail.com. Hauptthemen laut MEDLINE: Keratoacanthoma, Carcinoma, Squamous Cell, Skin Neoplasms. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Servicio de Dermatología, Hospital General Universitario de Albacete, Albacete, Spain. Electronic address: lopezsanzpablo@gmail.com.
- Servicio de Dermatología, Hospital Universitario de Navarra, Pamplona, Spain.
- Servicio de Dermatología, Hospital General Universitario de Albacete, Albacete, Spain.
Zitieren
APA
López Sanz, P., Fernández-Parrado, M., & Escario Travesedo, E. (2024). [Translated article] Differentiating Keratoacanthoma From Squamous Cell Carcinoma: Are We Losing the Battle or Our Bearings? — Comment on “Intralesional Methotrexate for Keratoacanthomas: A Case Series”. Actas Dermo-Sifiliográficas. https://doi.org/10.1016/j.ad.2024.01.010
Vancouver
López Sanz P, Fernández-Parrado M, Escario Travesedo E. [Translated article] Differentiating Keratoacanthoma From Squamous Cell Carcinoma: Are We Losing the Battle or Our Bearings? — Comment on “Intralesional Methotrexate for Keratoacanthomas: A Case Series”. Actas Dermo-Sifiliográficas. 2024. doi:10.1016/j.ad.2024.01.010
BibTeX
@article{LpezSanz2024,
author = {López Sanz, P and Fernández-Parrado, M and Escario Travesedo, E},
title = {[Translated article] Differentiating Keratoacanthoma From Squamous Cell Carcinoma: Are We Losing the Battle or Our Bearings? — Comment on “Intralesional Methotrexate for Keratoacanthomas: A Case Series”},
journal = {Actas Dermo-Sifiliográficas},
year = {2024},
doi = {10.1016/j.ad.2024.01.010}
}
EUVIMED